Thereafter, we carried out peptide-based immunotherapy against various types of cancer in which Lck-derived peptides were vaccinated into HLA-A24+ or -A2+ cancer patients (Sato et al, 2003; Mine et al, 2004). Here, LCK is linked to cancer.